Healthcare Systems & Policy

California says the expense of new hep C drugs has nothing to do with who is prescribed them. But the question lingers: With some 200,000 people living with hep C in Medi-Cal, how much of a factor is cost in determining which patients receive treatment?

Health Insurance and Costs

New hepatitis C treatments are both staggeringly effective and expensive. This has sparked a nationwide discussion about the high cost of specialty drugs and how such costs are keeping patients from needed treatments. Prescribing data may offer new insights.

Health Insurance and Costs

Starting in 2007, California’s hospital administrative penalties program was designed to bring greater accountability to hospitals that commit “never events” and put patients in immediate jeopardy. So, what does the data tell us about how well it's working?

Healthcare Regulation and Reform, Patient Safety and Ethics

Medicare marked its 50th anniversary earlier this year, but that doesn’t mean it’s time to celebrate for the popular public program. The youngest Baby Boomers will turn 65 in 2030, the beginning of a demographic tsunami made will also see seniors living longer and with more disabilities and chronic

Nevada is serving a greater number of mentally ill children in recent years. “This is an epidemic,” said Dr. Jay Fisher. Decades ago, he said, physicians looked to vaccines to preventing epidemics. “This is going to be much more difficult to solve. It’s a 12-headed beast.”

Health Insurance and Costs, Mental Health

These seven tropical diseases are closer to home than you think. Lurking in Dallas-area backyards is Chagas disease, caused by a parasite that infects more than 300,000 Americans. The disease can cause heart failure and death in humans and dogs and is often missed by doctors.

Chronic Disease